Targeted Therapy Prediction
Targeted Therapy Prediction - Related Videos
02:57
Targeted Cancer Therapies
0 Views •
2021
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body. There are several types of targeted therapies against specific...
02:57
Targeted Cancer Therapies
0 Views •
2023
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body. There are several types of targeted therapies against specific...
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
0 Views •
Cited by 7 •
2016
Photodynamic therapy (PDT) is an alternative choice for lung cancer treatment. To increase the therapeutic effect of PDT, lung cancer-targeted nanoparticles combined with chemotherapy were developed. Both in vitro and in vivo anticancer efficacies of PDT with prepared nanoparticles were evaluated.
10:21
Protein Target Prediction and Validation of Small Molecule Compound
0 Views •
2024
The experiment used here shows a method of molecular docking combined with cellular thermal shift assay to predict and validate the interaction between small molecules and protein targets.
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
0 Views •
Cited by 4 •
2016
Methods to evaluate the efficacy and toxicity of RNA molecules targeting post-integration steps of the HIV-1 replication cycle are described. These methods are useful for screening new molecules and optimizing the format of existing ones.
FAQs
Prediction becomes more informative when genomic alterations, protein expression, disease characteristics, and prior treatment response are considered together rather than treated as isolated observations. These inputs describe both the biology of the disease and the patient’s treatment history. Combining them helps associate an individual profile with likely therapeutic sensitivity or resistance, supporting a more evidence-informed treatment choice.
Biomarkers provide biological signals that can be linked with therapeutic sensitivity or resistance. Among the relevant patient inputs are genomic alterations and protein expression. Their value comes from helping computational or statistical models connect molecular features with expected treatment behavior, supporting identification of patients more likely to benefit from a molecularly directed therapy.
Computational and statistical models turn complex patient information into an estimate that can be compared with possible treatment responses. Rather than relying on one feature alone, the modeling approach can associate a combination of genomic, protein, disease, and treatment-history factors with sensitivity or resistance. This supports systematic interpretation of patient data when considering molecularly directed options.
An assessment can draw on four broad information categories: genomic alterations, protein expression, disease characteristics, and prior treatment response. These data are combined with a computational or statistical model to estimate the likelihood of sensitivity or resistance. The resulting prediction helps connect a patient’s specific profile with candidate molecularly directed treatments for consideration.
By estimating which molecularly directed treatment is most likely to be effective, the approach can help distinguish options with a stronger predicted fit from those less likely to benefit the patient. That information supports treatment selection and may reduce exposure to ineffective therapies. It therefore contributes to individualized care strategies.
Targeted therapy prediction informs clinical trial design by helping researchers connect patient characteristics with likely therapeutic sensitivity or resistance. It also supports investigation of treatment resistance, an area relevant to understanding why a molecularly directed therapy may not be effective for every patient. These research uses can guide development of more individualized care strategies.